
Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis
Author(s) -
Mahsa Abassi,
Ananta S Bangdiwala,
Edwin Nuwagira,
Kiiza Kandole Tadeo,
Michael Okirwoth,
Darlisha A Williams,
Edward Mpoza,
Lillian Tugume,
Kenneth Ssebambulidde,
Kathy Huppler Hullsiek,
Abdu K Musubire,
Conrad Muzoora,
Joshua Rhein,
David B. Meya,
David R. Boulware
Publication year - 2020
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciaa1749
Subject(s) - cerebrospinal fluid , medicine , csf albumin , gastroenterology , meningitis , viral meningitis , hazard ratio , confidence interval , surgery , bacterial meningitis
Cerebrospinal fluid (CSF) lactate levels can be used to differentiate between bacterial and viral meningitis. We measured CSF lactate in individuals with cryptococcal meningitis to determine its clinical significance.